1Executive Summary 1.1 Cancer Biomarker – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Cancer Biomarker Market Definition And Segmentation
6.4 Market Segmentation By Biomarkers Type
6.4.1 Protein Biomarkers
6.4.2 Genetic Biomarkers
6.4.3 Other Cancer Biomarkers
6.5 Market Segmentation By Profiling Technologies
6.5.1 Omics Technologies
6.5.2 Imaging Technologies
6.5.3 Immunoassays
6.5.4 Bioinformatics
6.5.5 Cytogenetics
6.6 Market Segmentation By Cancer Type
6.6.1 Cervical Cancer
6.6.2 Breast Cancer
6.6.3 Lung Cancer
6.6.4 Colorectal Cancer
6.6.5 Prostate Cancer
6.6.6 Brain And Central Nervous System Cancer
6.6.7 Kidney Cancer
6.6.8 Ovarian Cancer
6.6.9 Stomach Cancer
6.6.10 Other Cancer Types
6.7 Market Segmentation By Application
6.7.1 Diagnostics
6.7.2 Research And Development
6.7.3 Prognostics
6.7.4 Risk Assessment
6.7.5 Other Applications
7 Major Market Trends
7.1 Focus On AI Solution For Advancing Cancer Diagnostics And Cancer Drugs
7.2 Strategic Partnerships And Collaborations To Strengthen Market Position
7.3 Establishment Of Centre Of Excellence To Develop Biomarkers For Early Detection Of Cancer
7.4 Developments In Blood-Borne Circulating Biomarkers For Cancer Detection
7.5 Focus On Development Of Radioligand Therapy For Cancer Biomarker
8 Cancer Biomarker Market - Macro Economic Scenario
8.1 COVID-19 Impact On The Cancer Biomarker Market
8.2 Impact Of The War In Ukraine On The Cancer Biomarker Market
8.3 Impact Of High Inflation On The Cancer Biomarker Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
9.2.1 Market Drivers 2018 – 2023
9.2.2 Market Restraints 2018 – 2023
9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 – 2028
9.3.2 Market Restraints 2023 – 2028
10 Global Cancer Biomarker Market Segmentation
10.1 Global Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Cancer Biomarker Market, Regional and Country Analysis
11.1 Global Cancer Biomarker Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Cancer Biomarker Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Cancer Biomarker Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
12.9.1 Country Information
12.9.2 Market Information
12.9.3 Background Information
12.9.4 Government Initiatives
12.9.5 Regulations
12.9.6 Regulatory Bodies
12.9.7 Major Associations
12.9.8 Taxes Levied
12.9.9 Corporate Tax Structure
12.9.10 Investments
12.9.11 Major Companies
12.10 China Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.11 China Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.12 China Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.15 India Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.16 India Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Market
12.18 Japan Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Market
12.22 Australia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.24 Australia Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.32 South Korea Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Cancer Biomarker Market: Country Analysis
13.7 UK Market
13.8 UK Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.17 France Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.18 France Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 Eastern Europe Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Cancer Biomarker Market: Country Analysis
14.7 Russia Market
14.8 Russia Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Cancer Biomarker Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.1 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 South America Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Cancer Biomarker Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Middle East Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Investments
18.2.11 Major Companies
18.3 Africa Cancer Biomarker Market, Segmentation By Biomarkers Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Cancer Biomarker Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Roche Diagnostics
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Novartis AG
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Performance
19.4 Illumina Inc.
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Hologic Inc
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Thermo Fisher Scientific Inc.
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial performance
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 Novartis Acquired MorphoSys
22.2 Bristol Myers Squibb Acquired Mirati Therapeutics
22.3 Agilent Acquired Avida Biomed
22.4 Quest Diagnostics Acquired Haystack Oncology
22.5 Prenetics Global Acquired ACT Genomics
22.6 Biocare Medical Acquired Empire Genomics
22.7 Agilent Acquired Resolution Bioscience
22.8 Hologic Acquired Biotheranostics
23 Opportunities And Strategies
23.1 Global Cancer Biomarker Market In 2028 – Countries Offering Most New Opportunities
23.2 Global Cancer Biomarker Market In 2028 – Segments Offering Most New Opportunities
23.3 Global Cancer Biomarker Market In 2028 – Growth Strategies
23.3.1 Market Trend Based Strategies
23.3.2 Competitor Strategies
24 Cancer Biomarker Market, Conclusions And Recommendations
24.1 Conclusions
24.2 Recommendations
24.2.1 Product
24.2.2 Place
24.2.3 Price
24.2.4 Promotion
24.2.5 People
25 Appendix
25.1 Geographies Covered
25.2 Market Data Sources
25.3 Research Methodology
25.4 Currencies
25.5 The Business Research Company
25.6 Copyright and Disclaimer